Prio Wealth Limited Partnership Biogen Inc. Transaction History

Prio Wealth Limited Partnership

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 17, 2022	SELL	$223.92 - $287.77 $171,074 - $219,856	-764 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $197,876 - $316,838	764 New	764 $265,000
Q2 2020 Aug 11, 2020	SELL	$258.66 - $342.55 $165,542 - $219,232	-640 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $9,140 - $11,595	-34 Reduced 5.04%	640 $202,000
Q4 2019 Feb 10, 2020	BUY	$220.06 - $304.07 $148,320 - $204,943	674 New	674 $200,000
Q1 2019 May 03, 2019	SELL	$216.71 - $338.96 $159,715 - $249,813	-737 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$278.5 - $352.75 $27,850 - $35,275	100 Added 15.7%	737 $221,000
Q3 2018 Nov 07, 2018	SELL	$293.51 - $383.83 $56,940 - $74,463	-194 Reduced 23.35%	637 $225,000
Q2 2018 Aug 06, 2018	BUY	$257.52 - $306.91 $515 - $613	2 Added 0.24%	831 $241,000
Q1 2018 Apr 17, 2018	BUY	$260.13 - $367.91 $215,647 - $304,997	829 New	829 $226,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Prio Wealth Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Prio Wealth Limited Partnership with notifications on news.